HopeStage
Back to all studies
Active Not RecruitingNCT04325529

Brain imaging of approach and avoidance after depression remission

About this titleRead the official source — NCT04325529
Observational studyAges 18–45United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 45 years.

Listed locations
BelmontSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 19, 2021
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
148
Sponsor
Mclean Hospital
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
Device
Locations
United States
Age range
From 18 Years to 45 Years
Official registry ID
NCT04325529
Official title
Show the full official title

Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making

Recruitment & locations

Not recruiting

Belmont

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Mclean Hospital, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 45 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies